{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:38:34Z","timestamp":1790995114765,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Doctorate scholarship"],"award-info":[{"award-number":["Doctorate scholarship"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Doctorate scholarship"],"award-info":[{"award-number":["Doctorate scholarship"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Doctorate scholarship"],"award-info":[{"award-number":["Doctorate scholarship"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["PDJ scholarship (175855\/2023-4)"],"award-info":[{"award-number":["PDJ scholarship (175855\/2023-4)"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["CNPq\/MCTI\/ CT-Saude Call \u2013 Research, development and innovation in long COVID); notice n\u00b053\/2022 (RECLAIM Brazil Study)"],"award-info":[{"award-number":["CNPq\/MCTI\/ CT-Saude Call \u2013 Research, development and innovation in long COVID); notice n\u00b053\/2022 (RECLAIM Brazil Study)"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004916","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Amazonas","doi-asserted-by":"publisher","award":["Call No. 038\/2022 - PDPG\/CAPES\/FAPEAM"],"award-info":[{"award-number":["Call No. 038\/2022 - PDPG\/CAPES\/FAPEAM"]}],"id":[{"id":"10.13039\/501100004916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004916","name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado do Amazonas","doi-asserted-by":"crossref","award":["Call No. 006\/2020 \u2013 PCTI-EMERGESA\u00daDE\/AM \u2013 Priority Areas"],"award-info":[{"award-number":["Call No. 006\/2020 \u2013 PCTI-EMERGESA\u00daDE\/AM \u2013 Priority Areas"]}],"id":[{"id":"10.13039\/501100004916","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004916","name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado do Amazonas","doi-asserted-by":"crossref","award":["Call No. 006\/2020 \u2013 PCTI-EMERGESA\u00daDE\/AM \u2013 Priority Areas"],"award-info":[{"award-number":["Call No. 006\/2020 \u2013 PCTI-EMERGESA\u00daDE\/AM \u2013 Priority Areas"]}],"id":[{"id":"10.13039\/501100004916","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Persistent gastrointestinal (GI) symptoms are increasingly recognized as part of long COVID, yet their underlying mechanisms remain poorly defined. We conducted an exploratory case-series study of 80 adults hospitalized with severe COVID-19 in March-May 2020 in Manaus, Brazil. Two years post-infection, participants underwent structured clinical interviews and longitudinal cytokine analysis (IL-1\u03b2, IL-6, IL-8, IL-10, IL-12, and TNF-\u03b1). Overall, 30 participants reported ongoing GI symptoms (GI group) predominantly gastroesophageal reflux (63%), abdominal pain (43%), and diarrhea (37%). Compared with participants without GI symptoms (nGI group,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200950), the GI group reported a higher burden of additional long COVID symptoms, including palpitations, headache, and arthralgia. They also exhibited distinct clinical and laboratory features, including lower baseline creatinine and ferritin levels and altered platelet indices. Although IL-6 levels were lower during the acute hospitalization phase, they became significantly elevated at four months post-infection (D120,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.005), suggesting delayed inflammatory response. Ascendent biomarker analysis identified TNF-\u03b1 as highly expressed in a large proportion of GI group. The findings suggest GI problems can persist two years after severe COVID-19, and long-term inflammatory dysregulation may underlie the pathogenesis of these GI manifestations in long COVID. Prolonged gastrointestinal surveillance in COVID-19 survivors is necessary.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-37595-8","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T14:23:55Z","timestamp":1769696635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical features and inflammatory signatures of patients with persistent gastrointestinal long COVID two years after severe SARS-CoV-2 infection"],"prefix":"10.1038","volume":"16","author":[{"given":"Arlene","family":"dos Santos Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Irungu","family":"Mwangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Costa Ferreira","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Bezerra Silva","family":"Maciel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre V.","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson","family":"da Silva Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisely Cardoso","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuelton Marcelo","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanderson","family":"de Souza Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson Guimar\u00e3es","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando F.","family":"Almeida-Val","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"37595_CR1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","volume":"185","author":"Y Su","year":"2022","unstructured":"Su, Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185, 881\u2013895e20 (2022).","journal-title":"Cell"},{"key":"37595_CR2","doi-asserted-by":"crossref","unstructured":"Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133\u2013146 (2023).","DOI":"10.1038\/s41579-022-00846-2"},{"key":"37595_CR3","unstructured":"WHO. Post COVID-19 condition (Long COVID) (2022). https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/post-covid-19-condition."},{"key":"37595_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","volume":"404","author":"T Greenhalgh","year":"2024","unstructured":"Greenhalgh, T., Sivan, M., Perlowski, A. & Nikolich, J. Long COVID: a clinical update. Lancet 404, 707\u2013724 (2024).","journal-title":"Lancet"},{"key":"37595_CR5","doi-asserted-by":"publisher","first-page":"852","DOI":"10.2174\/1389557523666221116154907","volume":"23","author":"R Afrisham","year":"2023","unstructured":"Afrisham, R. et al. Gastrointestinal, liver, pancreas, oral and psychological long-term symptoms of COVID-19 after recovery: a review. Mini Rev. Med. Chem. 23, 852\u2013868 (2023).","journal-title":"Mini Rev. Med. Chem."},{"key":"37595_CR6","doi-asserted-by":"crossref","unstructured":"Xu, E., Xie, Y. & Al-Aly, Z. Long-term Gastrointestinal outcomes of COVID-19. Nat. Commun. 14, 856 (2023).","DOI":"10.1038\/s41467-023-36223-7"},{"key":"37595_CR7","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/ueg2.70005","volume":"13","author":"G Marasco","year":"2025","unstructured":"Marasco, G. et al. Long-Term impact of COVID-19 on disorders of Gut-Brain interaction: incidence, symptom Burden, and psychological comorbidities. United Eur. Gastroenterol. J. 13, 798\u2013818 (2025).","journal-title":"United Eur. Gastroenterol. J."},{"key":"37595_CR8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3350\/cmh.2024.0203","volume":"30","author":"K Lee","year":"2024","unstructured":"Lee, K. et al. Long-term Gastrointestinal and hepatobiliary outcomes of COVID-19: a multinational population-based cohort study from South Korea, Japan, and the UK. Clin. Mol. Hepatol. 30, 943\u2013958 (2024).","journal-title":"Clin. Mol. Hepatol."},{"key":"37595_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-023-03236-4","volume":"22","author":"Y Ma","year":"2024","unstructured":"Ma, Y. et al. Risks of digestive diseases in long COVID: evidence from a population-based cohort study. BMC Med. 22, 1\u201311 (2024).","journal-title":"BMC Med."},{"key":"37595_CR10","doi-asserted-by":"crossref","unstructured":"Thaweethai, T. et al. Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort. Nat. Commun. 16, 9557- (2025).","DOI":"10.1038\/s41467-025-65239-4"},{"key":"37595_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.gtc.2022.09.002","volume":"52","author":"A Rizvi","year":"2023","unstructured":"Rizvi, A., Ziv, Y., Crawford, J. M. & Trindade, A. J. Gastrointestinal and hepatobiliary symptoms and disorders with long (Chronic) COVID infection. Gastroenterol. Clin. North. Am. 52, 139 (2023).","journal-title":"Gastroenterol. Clin. North. Am."},{"key":"37595_CR12","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1093\/trstmh\/trab042","volume":"115","author":"JC Kariyawasam","year":"2021","unstructured":"Kariyawasam, J. C., Jayarajah, U., Riza, R., Abeysuriya, V. & Seneviratne, S. L. Gastrointestinal manifestations in COVID-19. Trans. R Soc. Trop. Med. Hyg. 115, 1362\u20131388 (2021).","journal-title":"Trans. R Soc. Trop. Med. Hyg."},{"key":"37595_CR13","doi-asserted-by":"publisher","first-page":"14822","DOI":"10.3390\/ijms241914822","volume":"24","author":"NC Moreno-Corona","year":"2023","unstructured":"Moreno-Corona, N. C. et al. Dynamics of the microbiota and its relationship with Post-COVID-19 syndrome. Int. J. Mol. Sci. 24, 14822 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"37595_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271 (2020).","journal-title":"Cell"},{"key":"37595_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.stemcr.2024.03.008","volume":"19","author":"M Pau\u017euolis","year":"2024","unstructured":"Pau\u017euolis, M. et al. SARS-CoV-2 tropism to intestinal but not gastric epithelial cells is defined by limited ACE2 expression. Stem Cell. Rep. 19, 629\u2013638 (2024).","journal-title":"Stem Cell. Rep."},{"key":"37595_CR16","doi-asserted-by":"publisher","first-page":"100663","DOI":"10.1016\/j.xcrm.2022.100663","volume":"3","author":"C Schulthei\u00df","year":"2022","unstructured":"Schulthei\u00df, C. et al. The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell. Rep. Med. 3, 100663 (2022).","journal-title":"Cell. Rep. Med."},{"key":"37595_CR17","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.3390\/microorganisms11102396","volume":"11","author":"J Alonso-Dom\u00ednguez","year":"2023","unstructured":"Alonso-Dom\u00ednguez, J. et al. High levels of IL-1\u03b2, TNF-\u03b1 and MIP-1\u03b1 one month after the onset of the acute SARS-CoV-2 Infection, predictors of post COVID-19 in hospitalized patients. Microorganisms 11, 2396 (2023).","journal-title":"Microorganisms"},{"key":"37595_CR18","doi-asserted-by":"publisher","first-page":"e2455430","DOI":"10.1001\/jamanetworkopen.2024.55430","volume":"8","author":"DP Shah","year":"2025","unstructured":"Shah, D. P. et al. Sex differences in long COVID. JAMA Netw. Open. 8, e2455430\u2013e2455430 (2025).","journal-title":"JAMA Netw. Open."},{"key":"37595_CR19","doi-asserted-by":"publisher","first-page":"1038227","DOI":"10.3389\/fimmu.2022.1038227","volume":"13","author":"M Bellan","year":"2022","unstructured":"Bellan, M. et al. Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study. Front. Immunol. 13, 1038227 (2022).","journal-title":"Front. Immunol."},{"key":"37595_CR20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3904\/kjim.2024.217","volume":"40","author":"JS Kwon","year":"2025","unstructured":"Kwon, J. S. et al. Cytokine profiles associated with persisting symptoms of post-acute sequelae of COVID-19. Korean J. Intern. Med. 40, 667 (2025).","journal-title":"Korean J. Intern. Med."},{"key":"37595_CR21","doi-asserted-by":"publisher","first-page":"1168487","DOI":"10.3389\/fmed.2023.1168487","volume":"10","author":"D Krenytska","year":"2023","unstructured":"Krenytska, D. et al. Circulating levels of inflammatory cytokines and angiogenesis-related growth factors in patients with osteoarthritis after COVID-19. Front. Med. (Lausanne). 10, 1168487 (2023).","journal-title":"Front. Med. (Lausanne)"},{"key":"37595_CR22","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/1873-3468.14201","volume":"596","author":"D Millrine","year":"2022","unstructured":"Millrine, D., Jenkins, R. H., Hughes, S. T. O. & Jones, S. A. Making sense of IL-6 signalling cues in pathophysiology. FEBS Lett. 596, 567\u2013588 (2022).","journal-title":"FEBS Lett."},{"key":"37595_CR23","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.3390\/ijms19113528","volume":"19","author":"M Narazaki","year":"2018","unstructured":"Narazaki, M. & Kishimoto, T. The Two-Faced cytokine IL-6 in host defense and diseases. Int. J. Mol. Sci.  19, 3528 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"37595_CR24","doi-asserted-by":"crossref","unstructured":"Montazersaheb, S. et al. COVID-19 infection: an overview on cytokine storm and related interventions. Virol. J. 19, 1\u201315 (2022).","DOI":"10.1186\/s12985-022-01814-1"},{"key":"37595_CR25","doi-asserted-by":"crossref","unstructured":"Chen, L. Y. C. et al. Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome. Cell Rep. Med 2, 4523 (2021).","DOI":"10.1016\/j.xcrm.2021.100269"},{"key":"37595_CR26","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/liv.13430","volume":"37","author":"A Iracheta-Vellve","year":"2017","unstructured":"Iracheta-Vellve, A. et al. Interleukin-1 Inhibition facilitates recovery from liver injury and promotes regeneration of hepatocytes in alcoholic hepatitis in mice. Liver Int. 37, 968\u2013973 (2017).","journal-title":"Liver Int."},{"key":"37595_CR27","doi-asserted-by":"publisher","first-page":"458876","DOI":"10.3389\/fimmu.2019.02014","volume":"10","author":"L Barbier","year":"2019","unstructured":"Barbier, L. et al. Interleukin-1 family cytokines: keystones in liver inflammatory diseases. Front. Immunol. 10, 458876 (2019).","journal-title":"Front. Immunol."},{"key":"37595_CR28","doi-asserted-by":"publisher","first-page":"803","DOI":"10.15789\/1563-0625-PCV-2843","volume":"25","author":"MA Urevskii","year":"2023","unstructured":"Urevskii, M. A., Ilmukhina, L. V., Saranskaya, Y. E., Lapshin, A. A. & Gafurova, R. R. Proinflammatory cytokines vegfa, IL-6, IL-8 as markers of hepatotoxicity after COVID-19. Med. Immunol. (Russia). 25, 803\u2013808 (2023).","journal-title":"Med. Immunol. (Russia)"},{"key":"37595_CR29","doi-asserted-by":"crossref","unstructured":"Cho, Y. E., Kim, Y., Kim, S. J., Lee, H. & Hwang, S. Overexpression of Interleukin-8 promotes the progression of fatty liver to nonalcoholic steatohepatitis in mice. Int J. Mol. Sci. 24, 7456 (2023).","DOI":"10.3390\/ijms242015489"},{"key":"37595_CR30","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.12998\/wjcc.v11.i10.2189","volume":"11","author":"M Helou","year":"2023","unstructured":"Helou, M., Nasr, J., Osta, N., El, Jabbour, E. & Husni, R. Liver manifestations in COVID-19 patients: a review article. World J. Clin. Cases. 11, 2189 (2023).","journal-title":"World J. Clin. Cases"},{"key":"37595_CR31","doi-asserted-by":"crossref","unstructured":"Zimmermann, H. W. et al. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One 6, 7456 (2011).","DOI":"10.1371\/journal.pone.0021381"},{"key":"37595_CR32","doi-asserted-by":"publisher","first-page":"113810","DOI":"10.1016\/j.biopha.2022.113810","volume":"155","author":"PJ Ma","year":"2022","unstructured":"Ma, P. J., Wang, M. M. & Wang, Y. Gut microbiota: a new insight into lung diseases. Biomed. Pharmacother. 155, 113810 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"37595_CR33","doi-asserted-by":"crossref","unstructured":"Lim, H. X., Khalid, K., Abdullah, A. D. I. & Lee, L. H. & Raja Ali, R. A. Subphenotypes of long COVID and the clinical applications of probiotics. Biomed. Pharmacotherapy 183, 526 (2025).","DOI":"10.1016\/j.biopha.2025.117855"},{"key":"37595_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41575-022-00611-z","volume":"19","author":"H Meringer","year":"2022","unstructured":"Meringer, H. & Mehandru, S. Gastrointestinal post-acute COVID-19 syndrome. Nat. Rev. Gastroenterol. Hepatol. 19, 345\u2013346 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"37595_CR35","doi-asserted-by":"publisher","first-page":"120162","DOI":"10.1016\/j.jns.2022.120162","volume":"434","author":"L Premraj","year":"2022","unstructured":"Premraj, L. et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J. Neurol. Sci. 434, 120162 (2022).","journal-title":"J. Neurol. Sci."},{"key":"37595_CR36","doi-asserted-by":"publisher","first-page":"983089","DOI":"10.3389\/fcimb.2022.983089","volume":"12","author":"K Vakili","year":"2022","unstructured":"Vakili, K. et al. The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: a hypothesis and review of literature. Front. Cell. Infect. Microbiol. 12, 983089 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"37595_CR37","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/01410768211032850","volume":"114","author":"OL Aiyegbusi","year":"2021","unstructured":"Aiyegbusi, O. L. et al. Symptoms, complications and management of long COVID: a review. J. R Soc. Med. 114, 428 (2021).","journal-title":"J. R Soc. Med."},{"key":"37595_CR38","doi-asserted-by":"publisher","first-page":"106297","DOI":"10.1016\/j.jinf.2024.106297","volume":"89","author":"A Dehlia","year":"2024","unstructured":"Dehlia, A. & Guthridge, M. A. The persistence of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) after SARS-CoV-2 infection: a systematic review and meta-analysis. J. Infect. 89, 106297 (2024).","journal-title":"J. Infect."},{"key":"37595_CR39","first-page":"378","volume":"14","author":"DG Basaca","year":"2025","unstructured":"Basaca, D. G. et al. Long COVID in children and adolescents: mechanisms, symptoms, and long-term impact on health\u2014a comprehensive review. J. Clin. Med. 2025. 14, 378 (2025).","journal-title":"J. Clin. Med. 2025"},{"key":"37595_CR40","doi-asserted-by":"publisher","unstructured":"National Academies of Sciences, E. Long-Term health effects of COVID-19: disability and function following SARS-CoV-2 infection. In Long-Term Health Effects of COVID-19 (National Academies, 2024). https:\/\/doi.org\/10.17226\/27756.","DOI":"10.17226\/27756"},{"key":"37595_CR41","doi-asserted-by":"crossref","unstructured":"Li, J. et al. The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID. Signal Transd. Targeted Therapy 8, 1\u201319 (2023).","DOI":"10.1038\/s41392-023-01640-z"},{"key":"37595_CR42","doi-asserted-by":"crossref","unstructured":"Maciel, A. B. S. et al. Inflammatory discoveries two years after acute severe COVID-19: a longitudinal biomarker profile assessment in long COVID individuals in the Brazilian Amazon. Front. Immunol. 15, 965 (2024).","DOI":"10.3389\/fimmu.2024.1520193"},{"key":"37595_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1473-3099(21)00460-6","volume":"22","author":"M Antonelli","year":"2022","unstructured":"Antonelli, M. et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect. Dis. 22, 43 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"37595_CR44","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.dld.2022.02.002","volume":"54","author":"J Samanta","year":"2022","unstructured":"Samanta, J., Singh, S., Kumar, S., Sharma, M. & Kochhar, R. Gastrointestinal sequelae among COVID-19 patients after discharge and their predictors. Dig. Liver Disease. 54, 580 (2022).","journal-title":"Dig. Liver Disease"},{"key":"37595_CR45","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","volume":"70","author":"YK Yeoh","year":"2021","unstructured":"Yeoh, Y. K. et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 70, 698\u2013706 (2021).","journal-title":"Gut"},{"key":"37595_CR46","doi-asserted-by":"crossref","unstructured":"Xie, Y., Bowe, B. & Al-Aly, Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat. Commun. 12, 586 (2021).","DOI":"10.1038\/s41467-021-26513-3"},{"key":"37595_CR47","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41591-022-02116-3","volume":"29","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat. Med. 29, 226\u2013235 (2023).","journal-title":"Nat. Med."},{"key":"37595_CR48","doi-asserted-by":"publisher","first-page":"916","DOI":"10.14309\/ajg.0000000000000664","volume":"115","author":"C Han","year":"2020","unstructured":"Han, C. et al. Digestive symptoms in COVID-19 patients with mild disease severity: clinical Presentation, stool viral RNA Testing, and outcomes. Am. J. Gastroenterol. 115, 916\u2013923 (2020).","journal-title":"Am. J. Gastroenterol."},{"key":"37595_CR49","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1111\/dom.14454","volume":"23","author":"A Aminian","year":"2021","unstructured":"Aminian, A., Bena, J., Pantalone, K. M. & Burguera, B. Association of obesity with postacute sequelae of COVID-19. Diabetes Obes. Metab. 23, 2183 (2021).","journal-title":"Diabetes Obes. Metab."},{"key":"37595_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cytogfr.2024.08.002","volume":"82","author":"A Hromi\u0107-Jahjefendi\u0107","year":"2025","unstructured":"Hromi\u0107-Jahjefendi\u0107, A. et al. The intersection of Microbiome and autoimmunity in long COVID-19: current insights and future directions. Cytokine Growth Factor. Rev. 82, 43\u201354 (2025).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"37595_CR51","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1002\/jmv.27684","volume":"94","author":"P Giannos","year":"2022","unstructured":"Giannos, P. & Prokopidis, K. Gut dysbiosis and long COVID-19: feeling gutted. J. Med. Virol. 94, 2917 (2022).","journal-title":"J. Med. Virol."},{"key":"#cr-split#-37595_CR52.1","unstructured":"Jeronimo, C. M. P. et al. Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19"},{"key":"#cr-split#-37595_CR52.2","unstructured":"Metcovid): a randomized, double-blind, phase IIb, Placebo-controlled trial. 72, E373-E381 (2021)."},{"key":"37595_CR53","doi-asserted-by":"publisher","first-page":"e208857","DOI":"10.1001\/jamanetworkopen.2020.8857","volume":"3","author":"MGS Borba","year":"2020","unstructured":"Borba, M. G. S. et al. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial. JAMA Netw. Open. 3, e208857\u2013e208857 (2020).","journal-title":"JAMA Netw. Open."},{"key":"37595_CR54","unstructured":"National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes Health (2024)."},{"key":"37595_CR55","unstructured":"WHO & Post COVID-19 condition (Long COVID) (2022). https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/post-covid-19-condition."},{"key":"37595_CR56","doi-asserted-by":"crossref","unstructured":"Neves, J. C. F. et al. CCL-2 and CXCL-8: potential prognostic biomarkers of acute kidney injury after a bothrops atrox snakebite. Mediators Inflamm. 2022, 8285084 (2022).","DOI":"10.1155\/2022\/8285084"},{"key":"37595_CR57","doi-asserted-by":"crossref","unstructured":"Garcia, N. P. et al. Sickle cell anemia patients display an intricate cellular and serum biomarker network highlighted by TCD4+CD69+ Lymphocytes, IL-17\/MIP-1\u03b2, IL-12\/VEGF, and IL-10\/IP-10 axis. J. Immunol. Res. 2020, 4585704 (2020).","DOI":"10.1155\/2020\/4585704"},{"key":"37595_CR58","doi-asserted-by":"publisher","first-page":"457024","DOI":"10.3389\/fimmu.2019.01882","volume":"10","author":"HNS Ibiapina","year":"2019","unstructured":"Ibiapina, H. N. S. et al. An immunological stairway to severe tissue complication assembly in Bothrops atrox snakebites. Front. Immunol. 10, 457024 (2019).","journal-title":"Front. Immunol."},{"key":"37595_CR59","doi-asserted-by":"publisher","first-page":"696032","DOI":"10.3389\/fonc.2021.696032","volume":"11","author":"MWA Kerr","year":"2021","unstructured":"Kerr, M. W. A. et al. Bone marrow soluble immunological mediators as clinical prognosis biomarkers in B-Cell acute lymphoblastic leukemia patients undergoing induction therapy. Front. Oncol. 11, 696032 (2021).","journal-title":"Front. Oncol."},{"key":"37595_CR60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/875647939000600106","volume":"6","author":"R Taylor","year":"1990","unstructured":"Taylor, R. Interpretation of the correlation coefficient: a basic review. J. Diagn. Med. Sonography. 6, 35\u201339 (1990).","journal-title":"J. Diagn. Med. Sonography"},{"key":"37595_CR61","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cyto.2018.04.008","volume":"110","author":"AG Costa","year":"2018","unstructured":"Costa, A. G. et al. Polymorphisms in TLRs influence Circulating cytokines production in plasmodium Vivax malaria: TLR polymorphisms influence cytokine productions in malaria-vivax. Cytokine 110, 374\u2013380 (2018).","journal-title":"Cytokine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37595-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37595-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37595-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:21:18Z","timestamp":1781630478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37595-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37595"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37595-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7375668\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6620"}}